All In Biotech

Drug Trial Radar · NCT00270634

Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

A Phase IIb, Randomized, Multicenter, Open-Label, Concentration Controlled, Safety Study of ISA247 (Voclosporin) and Tacrolimus (Prograf®) in De Novo Renal Transplant Patients

Last checked: Nov 19, 2026Latest source record: Feb 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 334 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

334

Actual

Start

Jan 2006

Primary completion

Jul 2009

Study completion Jul 2009

Sponsor

Lead sponsor
Aurinia Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Dec 28, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.

Conditions

  • Kidney Diseases

Interventions

  • VoclosporinDrug

    voclosporin 0.4, 0.6, 0.8 mg/kg po BID

  • tacrolimusDrug

    tacrolimus 0.05 mg/kg po BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Biopsy Proven Acute Rejection (BPAR)Time frame: Six months

Locations

45 sites in 2 countries. Site status is shown where the registry gives one.

  • Isotechnika Investigational Site

    Birmingham, Alabama

  • Isotechnika Investigational Site

    Los Angeles, California

  • Isotechnika Investigational Site

    Los Angeles, California

  • Isotechnika Investigational Site

    Los Angeles, California

  • Isotechnika Investigational Site

    Orange, California

  • Isotechnika Investigational Site

    Palo Alto, California

  • Isotechnika Investigational Site

    San Diego, California

  • Isotechnika Investigational Site

    San Francisco, California

  • Isotechnika Investigational Site

    Denver, Colorado

  • Isotechnika Investigational Site

    Gainesville, Florida

  • Isotechnika Investigational Site

    Tampa, Florida

  • Isotechnika Investigational Site

    Chicago, Illinois

  • Isotechnika Investigational Site

    Chicago, Illinois

  • Isotechnika Investigational Site

    Lexington, Kentucky

  • Isotechnika Investigational Site

    New Orleans, Louisiana

  • Isotechnika Investigational Site

    New Orleans, Louisiana

  • Isotechnika Investigational Site

    Baltimore, Maryland

  • Isotechnika Investigational Site

    Boston, Massachusetts

  • Isotechnika Investigational Site

    Ann Arbor, Michigan

  • Isotechnika Investigational Site

    Detroit, Michigan

  • Isotechnika Investigational Site

    Rochester, Minnesota

  • Isotechnika Investigational Site

    Livingston, New Jersey

  • Isotechnika Investigational Site

    Buffalo, New York

  • Isotechnika Investigational Site

    Hawthorne, New York

  • Isotechnika Investigational Site

    New York, New York

  • Isotechnika Investigational Site

    Rochester, New York

  • Isotechnika Investigational Site

    Durham, North Carolina

  • Isotechnika Investigational Site

    Winston-Salem, North Carolina

  • Isotechnika Investigational Site

    Cincinnati, Ohio

  • Isotechnika Investigational Site

    Cincinnati, Ohio

  • Isotechnika Investigational Site

    Portland, Oregon

  • Isotechnika Investigational Site

    Portland, Oregon

  • Isotechnika Investigational Site

    Portland, Oregon

  • Isotechnika Investigational Site

    Philadelphia, Pennsylvania

  • Isotechnika Investigational Site

    Philadelphia, Pennsylvania

  • Isotechnika Investigational Site

    Charleston, South Carolina

  • Isotechnika Investigational Site

    Memphis, Tennessee

  • Isotechnika Investigational Site

    Dallas, Texas

  • Isotechnika Investigational Site

    Houston, Texas

  • Isotechnika Investigational Site

    Richmond, Virginia

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.